Results 191 to 200 of about 2,091 (212)
Some of the next articles are maybe not open access.

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

Nature Medicine, 2022
Adriaan A Voors   +2 more
exaly  

Interaction between ACCase inhibitors and broadleaf herbicides to the control of Italian ryegrass

2021
Leal, Jéssica Ferreira Lourenço   +7 more
openaire   +1 more source

The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial

Nature Medicine, 2021
Barry A Borlaug   +2 more
exaly  

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

Risk of ovarian function recovery should be considered when switching from treatment with adjuvant tamoxifen to aromatase inhibitor therapy in women with chemotherapy-induced amenorrhea

Ca-A Cancer Journal for Clinicians, 2018
Clement Chung
exaly  

An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma

Nature, 2020
Ugur Sahin, Petra Oehm, Mathias Vormehr
exaly  

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Fadlo R Khuri
exaly  

NTRK fusion-positive cancers and TRK inhibitor therapy

Nature Reviews Clinical Oncology, 2018
Emiliano Cocco   +2 more
exaly  

The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy

Nature Reviews Cancer, 2019
Jonathan J Havel   +2 more
exaly  

Target Site Mechanism Confers Resistance Pattern of Accase-Inhibitors in Bearded Sprangletop from California

2023
Rasim Unan   +2 more
openaire   +1 more source
herbicide resistance
accase inhibitors
clethodim
accase
als inhibitor
target-site resistance
aryloxyphenoxypropionate
ryegrass
pinoxaden
previous   18  19  20  21  22  

Home - About - Disclaimer - Privacy